Richard Scalzo

Richard Scalzo

No más puestos en curso

Fortuna: 904 151 $ al 31/07/2026

40 años
Health Technology
Consumer Services

Perfil

Richard William Scalzo is Chief Financial Officer at Crescent Biopharma, Inc. since 2025.
Formerly, Mr. Scalzo was Controller at Dyne Therapeutics, Inc. from 2019 to 2020, Chief Accounting Officer at Kaleido Biosciences, Inc. in 2019, Controller at X4 Pharmaceuticals, Inc. from 2016 to 2018, Controller at Astellas Institute for Regenerative Medicine in 2014.
Education includes an undergraduate degree from Boston College conferred in 2008 and an MBA from the University of Massachusetts conferred in 2016.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/04/2026 24.243 ( 0,01 % ) 610 439 $ 31/07/2026
0,05 %
22/06/2026 20.298 ( 0,05 % ) 293 712 $ 31/07/2026

Cargos activos de Richard Scalzo

EmpresasCargoInicio

Antiguos cargos conocidos de Richard Scalzo.

EmpresasCargoFin
KALEIDO BIOSCIENCES, INC. Comptroller/Controller/Auditor 29/11/2019
X4 PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 01/08/2018
OCATA THERAPEUTICS INC Comptroller/Controller/Auditor 01/09/2014
DYNE THERAPEUTICS, INC. Director Financiero/CFO -
Ver el detalle de la experiencia de Richard Scalzo.

Formación de Richard Scalzo.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

92

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology